Metabolic-Dimension CKM Staging and MASLD Incidence in a Guangxi Cohort

A longitudinal health examination dataset from a community cohort in Guangxi, southern China, authored by Xinyang Long and last updated in May 2026. It contains data from 3,315 participants for cross-sectional analysis and longitudinal cohorts for studying incident MASLD and CKM stage progression. The dataset likely includes cardiometabolic component measurements and staging information.

Use Cases

• Predicting incident MASLD risk based on metabolic-dimension CKM staging.
• Identifying dominant cardiometabolic predictors like excess adiposity and hypertriglyceridemia.
• Analyzing the bidirectional relationship between MASLD and CKM stage progression.
• Validating ultrasonographic fatty liver as a sensitivity outcome for MASLD studies.

Strengths

• Includes longitudinal data with median follow-up periods of 2.61 and 1.77 years.
• Contains results from a forward cohort of 2,055 participants and an exploratory reverse cohort of 648 participants.
• Provides specific hazard ratios and odds ratios for associations between cardiometabolic components and MASLD.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data may reflect geographic bias inherent to a single community cohort in Guangxi, China.

Provenance

Source

figshare

Collection Method

Analysis of longitudinal health examination data from a community cohort.

Freshness

Last updated 2026-05-22 04:30:30; freshness should be verified.

Geography

Guangxi, southern China